| |
 |
|
Class Information
Number: 424/186.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same > Disclosed amino acid sequence derived from virus
Description: Subject matter wherein the disclosed amino acid sequence is derived from a viral protein or fragment thereof.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6174532 |
L2 immunogenic peptides of papillomavirus |
Jan. 16, 2001 |
| 6171592 |
Equine rhinovirus 1 proteins |
Jan. 9, 2001 |
| 6171591 |
Recombinant nodavirus compositions and methods |
Jan. 9, 2001 |
| 6165471 |
Homogeneous human papillomavirus capsomere containing compositions, methods for manufacture, and use thereof as diagnostic, prophylactic or therapeutic agents |
Dec. 26, 2000 |
| 6165730 |
Hepatitis C virus peptides obtained from the NS4 coding region and their use in diagnostic assays |
Dec. 26, 2000 |
| 6165477 |
Subunit immonogenic composition against dengue infection |
Dec. 26, 2000 |
| 6165470 |
Albumin derivatives with therapeutic functions |
Dec. 26, 2000 |
| 6162440 |
EBNA2 peptides and methods of using same |
Dec. 19, 2000 |
| 6159478 |
Recombinant canine herpesviruses |
Dec. 12, 2000 |
| 6156319 |
Soluble herpesvirus glycoprotein complex vaccine |
Dec. 5, 2000 |
| 6156314 |
Chimeric infectious bursal disease virus cDNA clones, expression products and vaccines based thereon |
Dec. 5, 2000 |
| 6156317 |
Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
Dec. 5, 2000 |
| 6149910 |
Peptides for the detection of HIV-1 group O |
Nov. 21, 2000 |
| 6133433 |
Method for detection and prevention of human cytomegalovirus infection |
Oct. 17, 2000 |
| 6120773 |
Recombinant herpes simplex viruses vaccines and methods |
Sep. 19, 2000 |
| 6117640 |
Recombinant vaccine made in E. coli against dengue virus |
Sep. 12, 2000 |
| 6113905 |
Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases |
Sep. 5, 2000 |
| 6113911 |
Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation method |
Sep. 5, 2000 |
| 6111068 |
HIV-1 p-17 peptide fragments, compositions containing and methods for producing and using same |
Aug. 29, 2000 |
| 6110466 |
Modified plant viruses as vectors |
Aug. 29, 2000 |
| 6110465 |
Nucleotide and deduced amino acid sequences of hypervariable region 1 of the envelope 2 gene of isolates of hepatitis C virus and the use of reagents derived from these hypervariable sequences |
Aug. 29, 2000 |
| 6103878 |
Antibody to carboxy-terminus of human herpesvirus 6 immediate early protein |
Aug. 15, 2000 |
| 6093794 |
Isolated peptides derived from the Epstein-Barr virus containing fusion inhibitory domains |
Jul. 25, 2000 |
| 6093535 |
Method for identifying attenuated chickenpox virus Oka strain or strain originating therein and acceptable as attenuated chickenpox vaccine virus |
Jul. 25, 2000 |
| 6090388 |
Peptide composition for prevention and treatment of HIV infection and immune disorders |
Jul. 18, 2000 |
| 6090390 |
Diagnostic test for equine arteritis virus mediated disease |
Jul. 18, 2000 |
| 6086880 |
Rotavirus peptide compositions and methods of use |
Jul. 11, 2000 |
| 6077510 |
Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases |
Jun. 20, 2000 |
| 6077511 |
Antigenic peptide derived from the G protein of RSV for type- and subtype-specific diagnosis of respiratory syncytial virus (RSV) infection |
Jun. 20, 2000 |
| 6074645 |
Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
Jun. 13, 2000 |
| 6071520 |
Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor |
Jun. 6, 2000 |
| 6066324 |
Carboxyl terminal of papilloma virus L1 region is not required for formation of virus-like particles |
May. 23, 2000 |
| 6060065 |
Compositions for inhibition of membrane fusion-associated events, including influenza virus transmission |
May. 9, 2000 |
| 6060308 |
RNA respiratory syncytial virus vaccines |
May. 9, 2000 |
| 6054130 |
Non-splicing variants of gp350/220 |
Apr. 25, 2000 |
| 6054131 |
Vaccine composition for herpes simplex virus and method of using |
Apr. 25, 2000 |
| 6048538 |
Peptides derived from the non-structural proteins of foot and mouth disease virus as diagnostic reagents |
Apr. 11, 2000 |
| 6036959 |
HCMV/HSV fusion glycoproteins |
Mar. 14, 2000 |
| 6034298 |
Vaccines expressed in plants |
Mar. 7, 2000 |
| 6033668 |
Chimeric protein which confers protection against parainfluenza virus and respiratory syncytial virus |
Mar. 7, 2000 |
| 6027729 |
NANBV Diagnostics and vaccines |
Feb. 22, 2000 |
| 6025141 |
Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form |
Feb. 15, 2000 |
| 6022542 |
Glycoprotein B of the RFHV/KSHV subfamily of herpes viruses |
Feb. 8, 2000 |
| 6020309 |
Pharmaceuticals based on papillomaviruses |
Feb. 1, 2000 |
| 6017535 |
cDNA sequence of Dengue virus serotype 1 (Singapore strain) |
Jan. 25, 2000 |
| 6017759 |
Chimeric infectious bursal disease virus cDNA clones, expression products and vaccines based thereon |
Jan. 25, 2000 |
| 6015566 |
Peptide composition generating an immune response against herpes virus |
Jan. 18, 2000 |
| 6013258 |
Immunogenic peptides from the HPV E7 protein |
Jan. 11, 2000 |
| 6013266 |
Live attenuated bacteria of the species Actinobacillus pleuropneumoniae |
Jan. 11, 2000 |
| 6013263 |
Measles virus peptides with antifusogenic and antiviral activities |
Jan. 11, 2000 |
|
|
|
